Results 191 to 200 of about 26,025 (223)

The use of venetoclax in the treatment of acute lymphoblastic leukemia-a systematic review. [PDF]

Ther Adv Med Oncol
Kowalczyk A, Zarychta J, Zawitkowska J, Lejman M.   +3 more
europepmc   +1 more source

Re-treatment of relapse in elderly AML with time-limited venetoclax-based regimen: a case report and literature review. [PDF]

Ann Hematol
Ng JY, Gullapalli V, Othman J, Talaulikar D.   +3 more
europepmc   +1 more source

Novel therapeutic strategies targeting resistance mechanisms in hematologic malignancies: from BCL2 inhibition to immunomodulatory approaches. [PDF]

Front Pharmacol
Han Q, Jiang S, Chen J, Xue L.
europepmc   +1 more source

[Rapid determination of venetoclax in plasma by ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]

Se Pu
Zhu Y, Ma XL, Yu SL, Qiu L.
europepmc   +1 more source

Venetoclax-based therapy in high-risk patients with relapsed/refractory multiple myeloma harboring t(11;14): a case report and review of the literature. [PDF]

J Med Case Rep
Yin J, Zhou X, Zhong Y.
europepmc   +1 more source

Case Report: Targeting the Achilles' heel of monomorphic epitheliotropic intestinal T-cell lymphoma. [PDF]

Front Oncol
Xue S, Gu HF, Yang F, Zhang W, Liu XY, Sun HP, Cao XY.   +6 more
europepmc   +1 more source

Have Fixed-Duration (FD) Regimens Delivered on Their Promise in Chronic Lymphocytic Leukemia and What Is the Future of FD Regimens? A Narrative Review. [PDF]

Adv Ther
Allan JN.
europepmc   +1 more source

Evaluation of mTOR, NFκB, and BCL-2 Inhibitor Activity In Vitro on Diffuse Large B-Cell Lymphoma Cells. [PDF]

Curr Issues Mol Biol
Majchrzak A, Mańka S, Cebula-Obrzut B, Mędra A, Robak P, Mikulski D, Witkowska M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Venetoclax

Reactions Weekly, 2023
Bereits im Jahr 1984 wurde das Protein BCL-2 als relevant für das Tumorgeschehen identifiziert, rekapitulierte Dr. Mary Ann Anderson, Melbourne (Australien), die Entwicklungsgeschichte von Venetoclax. Doch es sollten noch einige Jahrzehnte bis zur Marktreife der effektiven Substanz vergehen.
  +6 more sources

Venetoclax

Reactions Weekly, 2021
  +8 more sources